कोरिया में विश्वसनीय एक नया सैमसंग और मॉडर्ना वैक्सीन प्राधिकरण

इस लेख से क्या सीखें:

• Upon execution of the deal, Samsung Biologics successfully reduced the overall timeline by leveraging its technology and capabilities, enabling the first batch of Moderna’s COVID-19 vaccine to be released for domestic supply within five months from the signing of the contract.
• In May 2021, Moderna and Samsung Biologics announced the agreement for fill-finish manufacturing of the Moderna COVID-19 vaccine.
• eTurboNews लेख केवल ग्राहकों के लिए हैं.